Cannabinoid Clinic: CBDVA

This article is brought to you by the new Higher Learning LV Core Cannabis course.

---

Welcome to homework assignment 1.23 of the Core Cannabis Lite Track from Higher Learning LV. When you complete this assignment, simply click the link at the bottom of the article to return to the master page for this training track.

---

Welcome to Cannabinoid Clinic, an education project powered by Higher Learning LV. This series provides cannabis and hemp industry professionals with easily digested cannabinoid profiles that ask little of your time—but provide plenty of science-based information.

There are two categories of cannabinoids: Phytocannabinoids and endocannabinoids. Phytocannabinoids are those produced by cannabis/marijuana/hemp, while endocannabinoids are made by the human body. This series covers both.

CBDVA molecular structure

What is CBDVA?

Cannabidivarinic acid (CBDVA) is a specialized minor cannabinoid that serves as the acidic precursor that morphs into the varin cannabinoid CBDV under the right environmental conditions. This molecule belongs to a small family of closely related cannabinoids that includes cannabidiol (CBD) and cannabidiolic acid (CBDA).

"CBDVA has demonstrated anticonvulsant efficacy that may make it of value in the treatment of epilepsy, particularly childhood Dravet syndrome."

CBDVA was discovered in 1977 by Japanese researchers (along with the other varin-specific acidic precursors, THCVA and CBGVA). This cannabinoid has demonstrated anticonvulsant efficacy that may make it of value in the treatment of epilepsy, particularly childhood Dravet syndrome.

To see the Fast Facts and Research Studies sections that have been removed from this no-cost training asset, enroll in Core Cannabis.

---

Return to the Core Cannabis Lite Track master page.

Are you a cannabis industry professional? Check out Higher Learning LV's Deep Dive Subscription that features dozens of long-form articles based on the latest peer-reviewed scientific research. Priced to accommodate personal and enterprise training budgets.